Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

PT287 – Josh Hardman –  Psychedelic Stocks, Data Privacy, and Drug Development

PT287 – Josh Hardman – Psychedelic Stocks, Data Privacy, and Drug Development

FromPsychedelics Today


PT287 – Josh Hardman – Psychedelic Stocks, Data Privacy, and Drug Development

FromPsychedelics Today

ratings:
Length:
82 minutes
Released:
Jan 25, 2022
Format:
Podcast episode

Description

In this episode of the podcast, Joe interviews Josh Hardman, Founder and Editor of Psilocybin Alpha; a news website and weekly newsletter covering the psychedelic space with a focus on emerging companies and drug development.  www.psychedelicstoday.com
Released:
Jan 25, 2022
Format:
Podcast episode

Titles in the series (100)

A show discussing the important academic and other research in the field of Psychedelics. We discuss how psychedelics relate to human potential and healing.